SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator flaflyersfan, Doubledown22, Stock Barber, Badali, baryoboy, KBing617
Search This Board:
Last Post: 11/29/2015 9:53:20 AM - Followers: 455 - Board type: Free - Posts Today: 1

MAJOR NEWS HEADLINE ::::::::::::::::::: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#91633  Sticky Note Epgl on internet franck92 11/26/15 12:57:53 AM
#89899  Sticky Note $EPGL has MULTIPLE Patent Applications Published! Check it vikingzskillz 10/26/15 12:48:20 PM
#89713  Sticky Note Independently Confirmed: MEMS Journal ranks $EPGL as a vikingzskillz 10/22/15 08:38:17 AM
#91687   Not worried!! EPGL will get it done gman22 11/29/15 09:53:20 AM
#91686   I think like you , I would say franck92 11/28/15 05:04:16 PM
#91685   EPGL: If anything happened under .04 it Badali 11/28/15 02:18:40 PM
#91684   Many bigboards down and down big, the market vikingzskillz 11/28/15 01:33:38 PM
#91683   It means that we lose our money if FlipperChomps 11/28/15 01:28:08 PM
#91682   And then what happens to $EPGL after this Doubledown22 11/28/15 10:29:32 AM
#91681   Cyber Monday sale on epgl below .04 Volcanridge 11/28/15 07:39:15 AM
#91679   My point exactly. JonnyBGood 11/28/15 01:14:14 AM
#91677   The problem you just pointed out is that FlipperChomps 11/27/15 11:41:08 PM
#91676   About EPGL Medical Science's Share Structure : JonnyBGood 11/27/15 09:38:59 PM
#91675   Thanks! That very informative. Makes much more sense now. Beatnikguy 11/27/15 06:34:26 PM
#91674   Thanks a lot for the information. franck92 11/27/15 06:11:49 PM
#91673   5 weeks left to go! End of year FlipperChomps 11/27/15 06:08:33 PM
#91670   The markets is closed since 1 pm, Lmfao. franck92 11/27/15 02:48:15 PM
#91669   That is negotiation between a start up and franck92 11/27/15 02:46:17 PM
#91668   Im not gonna need to wish for it FlipperChomps 11/27/15 02:43:18 PM
#91665   Nooo..... You notice stock price stays the same FlipperChomps 11/27/15 02:27:05 PM
#91662   Dont forget again that justice, through PWC, have franck92 11/27/15 11:21:18 AM
#91661   Ever heard a washed-up scientist read utter nonsense Donguri 11/27/15 11:17:23 AM
#91660   With all this good news coming from ??????????? baryoboy 11/27/15 10:08:19 AM
#91659   How can you say they sell their stock franck92 11/27/15 09:13:38 AM
#91658   Sellers are flippers who were looking for some mfefree 11/27/15 08:28:42 AM
#91656   Their "end game" could be to just sell FlipperChomps 11/27/15 04:19:08 AM
#91655   Signs of hope. BitCapitals 11/27/15 03:52:49 AM
#91654   Lol....but you subscribe to the theory that unless Doubledown22 11/27/15 02:19:39 AM
#91653   How do they sell stock when the 499M jhnvtjll 11/27/15 01:16:41 AM
#91652   Looking forward to EPGL Christmas in July. jhnvtjll 11/27/15 01:08:18 AM
#91650   Are you saying those doctors personally took questions FlipperChomps 11/26/15 11:00:34 PM
#91649   Those "doctors" have been on many conference calls vikingzskillz 11/26/15 10:56:22 PM
#91648   Looks like a list of people epgl will FlipperChomps 11/26/15 10:52:38 PM
#91647   Doubledown22, the word "seems" is used a lot flaflyersfan 11/26/15 10:47:44 PM
#91646   Confirmation? Correct filing forms would be nice, for starters. FlipperChomps 11/26/15 10:43:42 PM
#91645   They do have few printing presses here4beer 11/26/15 10:17:29 PM
#91644   Agree 100% ->The same point Franck is making. vikingzskillz 11/26/15 09:59:59 PM
#91643  Restored The point is Flaffy, that $EPGL "parroted" all Doubledown22 11/26/15 09:52:04 PM
#91642   Good post. Badali 11/26/15 09:19:29 PM
#91640   In fact they sell shoes and sex toys. franck92 11/26/15 02:26:56 PM
#91639   If epgl are found out to be lying Koog 11/26/15 02:08:55 PM
#91636   Articles are here and independants till you prove franck92 11/26/15 11:39:20 AM
#91635   Doubledown22, all of those "articles" a simply parroting flaflyersfan 11/26/15 11:23:23 AM
#91634   Great post Franck....people act like $EPGL is sneaking Doubledown22 11/26/15 11:02:17 AM
#91633   Epgl on internet franck92 11/26/15 12:57:53 AM
#91632   Access DENIED. FlipperChomps 11/26/15 12:55:14 AM
#91631   Epgl threats COO of lawsuit in june = franck92 11/25/15 11:25:53 PM
#91630   No I'm not gonna pipe dream of some FlipperChomps 11/25/15 11:21:11 PM
#91629   Imagine now the opposite situation when licensing deal franck92 11/25/15 10:39:14 PM
#91628   Waaaay too many shares!!! You still got over FlipperChomps 11/25/15 10:31:13 PM
#91627   It is not a sell off and the franck92 11/25/15 08:21:49 PM
#91626   "There is absolutely nothing that can be said Beatnikguy 11/25/15 07:30:12 PM
#91625   Good buy Day today. franck92 11/25/15 06:27:10 PM